Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

Overview of attention for article published in Virology Journal, August 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog

twitter: 15 X users

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 79 Mendeley

Summary Blogs X Dimensions citations

So far, Dimensions has found 56 publications that cite this research output.

56

The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

Article in Science Translational Medicine (April 2024)

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.

Article in Journal of Virology (April 2024)

Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus

Article in Cell Reports Medicine (January 2024)